GILEAD SCIENCES, INC. : Le comité consultatif de la FDA soutient l ... - Zonebourse.com
GILEAD SCIENCES, INC.
Aurobindo Pharma receives final approval for Lamivudine+Zidovudine ... - Equity Bulls
Aurobindo Pharma receives final approval for Lamivudine+Zidovudine .
HIV positive patients face bleak future - NewsDay
HIV positive patients face bleak futureNewsDayZimbabwe started phasing out the combination anti-retroviral treatment (ARV) Stavudine, Lamivudine and Nevirapine as its first-line option for the national programme, replacing it with the less toxic Tenofovir and Zidovudine-based regimens.
Aurobindo gets approval for Lamivudine, Zidovudine tablets - Myiris.com
Aurobindo gets approval for Lamivudine, Zidovudine tabletsMyiris.
Lupin, Aurobindo get USFDA nod for HIV drug - Economic Times
Lupin, Aurobindo get USFDA nod for HIV drugEconomic TimesLupin Pharmaceuticals Inc, a subsidiary of Lupin Ltd, has received final approval from US Food and Drug Administration (USFDA) for its generic Lamivudine and Zidovudine combination tablet in strength of 150mg/300 mg, Lupin said in a statement.